Cancer nanomedicines and the development of state-of-the-art multifunctional lipid-based
nanoparticles (NPs) has become a fundamental resource in resolving challenging …

Cancer causes significant mortality and morbidity worldwide, but existing pharmacological
treatments are greatly limited by the inherent heterogeneity of cancer as a disease, as well …

Lipid nanoparticles (LNPs) are biocompatible drug delivery systems that have found
numerous applications in medicine. Their versatile nature enables the encapsulation and …

Currently, despite many active compounds have been introduced to the treatment, cancer
remains one of the most vital causes of mortality and reduced quality of life. Conventional …

Combination therapy, which targets different mechanisms responsible for tumor
development and proliferation, has become the norm for modern cancer treatment. The …

Today, researchers are constantly developing new nanomaterials, nanodevices, and
nanoparticles to meet unmet needs in the delivery of therapeutic agents and imaging agents …

Despite all the advances seen in recent years, the severe adverse effects and low specificity
of conventional chemotherapy are still challenging problems regarding cancer treatment …

The prospect of improved cancer chemotherapy using solid lipid nanoparticles (SLN) as a
drug delivery system is promising. Several obstacles frequently encountered with anticancer …

Cancer is a severe disease that results in death in all countries of the world. A nano-based
drug delivery approach is the best alternative, directly targeting cancer tumor cells with …

Cancer is one of the major leading causes of mortality in the world. The implication of
nanotherapeutics in cancer has garnered splendid attention owing to their capability to …